458 related articles for article (PubMed ID: 24255917)
1. CD169 mediates the capture of exosomes in spleen and lymph node.
Saunderson SC; Dunn AC; Crocker PR; McLellan AD
Blood; 2014 Jan; 123(2):208-16. PubMed ID: 24255917
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Protein and Peptide Targeting for the Development of a CD169-Based Vaccination Strategy Against Melanoma.
van Dinther D; Veninga H; Revet M; Hoogterp L; Olesek K; Grabowska J; Borg EGF; Kalay H; van Kooyk Y; den Haan JMM
Front Immunol; 2018; 9():1997. PubMed ID: 30237798
[TBL] [Abstract][Full Text] [Related]
3. Peripheral prion disease pathogenesis is unaltered in the absence of sialoadhesin (Siglec-1/CD169).
Bradford BM; Crocker PR; Mabbott NA
Immunology; 2014 Sep; 143(1):120-9. PubMed ID: 24684244
[TBL] [Abstract][Full Text] [Related]
4. The CD169 sialoadhesin molecule mediates cytotoxic T-cell responses to tumour apoptotic vesicles.
Black LV; Saunderson SC; Coutinho FP; Muhsin-Sharafaldine MR; Damani TT; Dunn AC; McLellan AD
Immunol Cell Biol; 2016 May; 94(5):430-8. PubMed ID: 26647968
[TBL] [Abstract][Full Text] [Related]
5. CD169
Camara A; Lavanant AC; Abe J; Desforges HL; Alexandre YO; Girardi E; Igamberdieva Z; Asano K; Tanaka M; Hehlgans T; Pfeffer K; Pfeffer S; Mueller SN; Stein JV; Mueller CG
Proc Natl Acad Sci U S A; 2022 Jan; 119(3):. PubMed ID: 35031565
[TBL] [Abstract][Full Text] [Related]
6. CD169+ Subcapsular Macrophage Role in Antigen Adjuvant Activity.
Lisk C; Yuen R; Kuniholm J; Antos D; Reiser ML; Wetzler LM
Front Immunol; 2021; 12():624197. PubMed ID: 33815376
[TBL] [Abstract][Full Text] [Related]
7. Targeted delivery of lipid antigen to macrophages via the CD169/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation.
Kawasaki N; Vela JL; Nycholat CM; Rademacher C; Khurana A; van Rooijen N; Crocker PR; Kronenberg M; Paulson JC
Proc Natl Acad Sci U S A; 2013 May; 110(19):7826-31. PubMed ID: 23610394
[TBL] [Abstract][Full Text] [Related]
8. A Protective Role for the Lectin CD169/Siglec-1 against a Pathogenic Murine Retrovirus.
Uchil PD; Pi R; Haugh KA; Ladinsky MS; Ventura JD; Barrett BS; Santiago ML; Bjorkman PJ; Kassiotis G; Sewald X; Mothes W
Cell Host Microbe; 2019 Jan; 25(1):87-100.e10. PubMed ID: 30595553
[TBL] [Abstract][Full Text] [Related]
9. Subcapsular sinus macrophage fragmentation and CD169+ bleb acquisition by closely associated IL-17-committed innate-like lymphocytes.
Gray EE; Friend S; Suzuki K; Phan TG; Cyster JG
PLoS One; 2012; 7(6):e38258. PubMed ID: 22675532
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of CD169-positive lymph node sinus macrophages in patients with endometrial carcinoma.
Ohnishi K; Yamaguchi M; Erdenebaatar C; Saito F; Tashiro H; Katabuchi H; Takeya M; Komohara Y
Cancer Sci; 2016 Jun; 107(6):846-52. PubMed ID: 26991548
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic and functional heterogeneity of CD169⁺ and CD163⁺ macrophages from porcine lymph nodes and spleen.
Alvarez B; Martínez P; Yuste M; Poderoso T; Alonso F; Domínguez J; Ezquerra A; Revilla C
Dev Comp Immunol; 2014 May; 44(1):44-9. PubMed ID: 24291017
[TBL] [Abstract][Full Text] [Related]
12. Sialoglycans on lymphatic endothelial cells augment interactions with Siglec-1 (CD169) of lymph node macrophages.
D'Addio M; Frey J; Tacconi C; Commerford CD; Halin C; Detmar M; Cummings RD; Otto VI
FASEB J; 2021 Nov; 35(11):e22017. PubMed ID: 34699642
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of CD169+ Lymph Node Sinus Macrophages in Patients with Malignant Melanoma.
Saito Y; Ohnishi K; Miyashita A; Nakahara S; Fujiwara Y; Horlad H; Motoshima T; Fukushima S; Jinnin M; Ihn H; Takeya M; Komohara Y
Cancer Immunol Res; 2015 Dec; 3(12):1356-63. PubMed ID: 26297710
[TBL] [Abstract][Full Text] [Related]
14. Possible functions of CD169-positive sinus macrophages in lymph nodes in anti-tumor immune responses.
Komohara Y; Ohnishi K; Takeya M
Cancer Sci; 2017 Mar; 108(3):290-295. PubMed ID: 28002629
[TBL] [Abstract][Full Text] [Related]
15. Retroviruses use CD169-mediated trans-infection of permissive lymphocytes to establish infection.
Sewald X; Ladinsky MS; Uchil PD; Beloor J; Pi R; Herrmann C; Motamedi N; Murooka TT; Brehm MA; Greiner DL; Shultz LD; Mempel TR; Bjorkman PJ; Kumar P; Mothes W
Science; 2015 Oct; 350(6260):563-567. PubMed ID: 26429886
[TBL] [Abstract][Full Text] [Related]
16. The identification and developmental requirements of colonic CD169⁺ macrophages.
Hiemstra IH; Beijer MR; Veninga H; Vrijland K; Borg EG; Olivier BJ; Mebius RE; Kraal G; den Haan JM
Immunology; 2014 Jun; 142(2):269-78. PubMed ID: 24883436
[TBL] [Abstract][Full Text] [Related]
17. CD169
Shaabani N; Duhan V; Khairnar V; Gassa A; Ferrer-Tur R; Häussinger D; Recher M; Zelinskyy G; Liu J; Dittmer U; Trilling M; Scheu S; Hardt C; Lang PA; Honke N; Lang KS
Cell Death Dis; 2016 Nov; 7(11):e2446. PubMed ID: 27809306
[TBL] [Abstract][Full Text] [Related]
18. Antigen targeting reveals splenic CD169+ macrophages as promoters of germinal center B-cell responses.
Veninga H; Borg EG; Vreeman K; Taylor PR; Kalay H; van Kooyk Y; Kraal G; Martinez-Pomares L; den Haan JM
Eur J Immunol; 2015 Mar; 45(3):747-57. PubMed ID: 25487358
[TBL] [Abstract][Full Text] [Related]
19. Antigen delivery to macrophages using liposomal nanoparticles targeting sialoadhesin/CD169.
Chen WC; Kawasaki N; Nycholat CM; Han S; Pilotte J; Crocker PR; Paulson JC
PLoS One; 2012; 7(6):e39039. PubMed ID: 22723922
[TBL] [Abstract][Full Text] [Related]
20. CD14 and CD169 expression in human lymph nodes and spleen: specific expansion of CD14+CD169- monocyte-derived cells in diffuse large B-cell lymphomas.
Marmey B; Boix C; Barbaroux JB; Dieu-Nosjean MC; Diebold J; Audouin J; Fridman WH; Mueller CG; Molina TJ
Hum Pathol; 2006 Jan; 37(1):68-77. PubMed ID: 16360418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
